In 1970, the Journal of Electrocardiology published an article by Ohio researcher Dr. J. William Spickler, who claimed to have designed a pacemaker small enough to fit entirely inside the heart's right ventricle. But the device, implanted in dogs, had too many problems to be viable. Forty-five years later, a team of more than 100 Medtronic PLC scientists and engineers based mainly in Minnesota has designed a tiny investigational pacemaker, the Micra, that fits inside the same heart chamber. It's one of two devices being tested on patients today that have a shot at fulfilling Spickler's vision of an "intracardiac pacemaker." (The other one, called the Nanostim, is made by St. Jude Medical.) The Star Tribune spoke with Medtronic's senior principal scientist on the Micra project, Matthew Bonner, who works in Mounds View. Following is an edited transcript:
Q: What makes you want to design medical devices?
A: Growing up, I've always loved to tinker with things. I tore apart my dad's sports car and rebuilt it in high school. Stuff like that. The medical part I enjoy because I like doing things to help people. It's a real standard answer, but especially in this project, where I've actually been out and seen the patients, and how much better they feel, it's just a great feeling. It makes it worth tinkering in the lab.
Q: How does it feel to hold a real Micra today, after years working with prototypes?
A: It's pretty spectacular. The first one we came up with, six years ago, I actually made it. It was a plastic cylinder, and it had paper clip tines (which affix it to the heart wall). Show-and-tell is half my job. The only way I can get people to understand, really, is to make something.
Q: Where did the idea come from to put a pacemaker into a space the size of a pill?
A: The idea is actually not new. A guy named Spickler published an article in 1970 in which he made a device that was not too different from this. But it didn't last very long, and they didn't have the technology to make it do everything that a pacemaker should do, and last as long as it should last.
So when we started this project, the thought was, we have the technology now to make the pacemaker perform all the same activities and things that a normal pacemaker does, but reduce the size by over 90 percent. That's what you are seeing here.